HAP Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

HAP Trading’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,014	Closed	-$200K	–	2989
2021 Q3	$241K	Buy	+54,014	New	+$260K	0.01%	960
2019 Q4	–	Sell	-360,468	Closed	-$2.62M	–	1554
2019 Q3	$1.42M	Buy	360,468 +109,274	+44%	+$884K	0.12%	153
2019 Q2	$3.73M	Buy	251,194 +234,693	+1,422%	+$4.24M	0.29%	74
2019 Q1	$410K	Buy	16,501 +1,076	+7%	+$27K	0.04%	320
2018 Q4	$277K	Sell	15,425 -119	-0.8%	-$2.43K	0.02%	488
2018 Q3	$457K	Buy	+15,544	New	+$602K	0.03%	309
2016 Q2	–	Sell	-93,408	Closed	-$1.79M	–	1083
2016 Q1	$1.79M	Buy	+93,408	New	+$1.98M	0.13%	136

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

HAP Trading's CLVS Position: Q4 2021 in Review

HAP Trading sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 54,014 shares — an estimated $200K sold.

HAP Trading first reported a position in CLVS in Q1 2016 and held it in 7 quarters. The position peaked at $3.73M in Q2 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

HAP Trading reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 54,014 Clovis Oncology, Inc. shares in Q4 2021, an estimated $200K.
HAP Trading first reported a position in Clovis Oncology, Inc. in Q1 2016 and held it in 7 quarters.
HAP Trading's Clovis Oncology, Inc. position peaked at $3.73M in Q2 2019.
154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.